SCHEDULE: Vanguard Group Amends 13G for Prestige Consumer Healthcare

The Vanguard Group filed an amended Schedule 13G for Prestige Consumer Healthcare Inc., reporting 0% beneficial ownership following an internal realignment.

Summary

• The Vanguard Group filed Amendment No. 17 to its Schedule 13G for Prestige Consumer Healthcare Inc. Common Stock.
• The filing reports 0% beneficial ownership of Prestige Consumer Healthcare Inc. Common Stock by The Vanguard Group.
• This change is attributed to an internal realignment within The Vanguard Group, Inc. that occurred on January 12, 2026.
• Following the realignment, certain subsidiaries or business divisions of The Vanguard Group, Inc. will now report beneficial ownership separately, in reliance on SEC Release No. 34-39538.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over the securities beneficially owned by these disaggregated subsidiaries and/or business divisions.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative update, reflecting an internal reporting realignment at The Vanguard Group rather than a change in investment strategy or performance for Prestige Consumer Healthcare Inc.

Management Comments

• The Vanguard Group, Inc. went through an internal realignment on January 12, 2026.
• Certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc. will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on SEC Release No. 34-39538.
• The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.
• Securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures for institutional investors. This specific amendment reflects an internal organizational change at The Vanguard Group, rather than a strategic investment decision related to Prestige Consumer Healthcare Inc. or broader industry trends. It does not indicate a change in investment thesis for the underlying assets, merely a change in how they are reported by Vanguard's various entities.

Stakeholder Impact

• Shareholders of Prestige Consumer Healthcare Inc. will observe a change in the reported beneficial ownership by The Vanguard Group, though the underlying investment may still be held by Vanguard's disaggregated entities.
• The Vanguard Group's internal realignment primarily impacts its own reporting structure and compliance with SEC regulations.

Key Dates

Keywords

Prestige Consumer Healthcare Inc, Vanguard Group, Schedule 13G, Beneficial Ownership, Common Stock, SEC Filing, Investment Adviser, Corporate Governance